PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Forevertek Biotechnology Co., Ltd

USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Forevertek ranks #26,329 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 5 technology areas.

#26,329
of 49,997 US assignees by volume
Top 33%
by Innovation Score (41.4/100)
8.6
avg claims per patent
+700%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26329 · Foreign Corporation #26,329 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #26,329/49,997
  • PHOTO-FINISH For Life Products
  • CPC-NARROW C07K · 5 areas
  • INNOV-PAR 41.4/100
  • CLAIMS-PAR 8.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +700% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: For Life Products, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Forevertek’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Forevertek

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Forevertek's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Forevertek?

Each dot is one of Forevertek’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Forevertek’s own 8.6 claims/patent is at or below the 14.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Forevertek vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 510152025 Granted patents (volume) Avg claims / patent For Life Products, LLC - 10, 10.3For Life ProductsForce10 Networks, Inc. - 10, 19.1Force10 NetworksForcepoint Federal Holdings LLC - 10, 18.3Forcepoint Federa…Forest Concepts, LLC - 10, 8.1Forest ConceptsFort Wayne Metals Research Products, LLC - 10, 22.3Fort Wayne Metals…Foster Findlay Associates Limited - 10, 19.5Foster Findlay As…Fourds Limited - 10, 10.5FourdsFourté International, SDN. BHD - 10, 14.7Fourté Internatio…Forevertek Biotechnology Co., Ltd - 10, 8.6Forevertek Biotec…
Forevertek vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Forevertek's grants concentrate

Forevertek Biotechnology Co., Ltd is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2018. By volume, Forevertek sits between For Life Products, LLC and Fourté International, SDN. BHD.

Forevertek's three-year grant acceleration

Forevertek Biotechnology Co., Ltd shows 7 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Forevertek's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Forevertek holds 10 patents at rank #26,338, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Forevertek

By rank, the assignees closest to #26,338 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Forevertek's primary technology class.

Forevertek's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 201820212022202320242025 1
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Forevertek Biotechnology Co., Ltd patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 10.0%
2021 1 10.0%
2022 1 10.0%
2023 2 20.0%
2024 4 40.0%
2025partial year 1 10.0%

Which technologies does Forevertek Biotechnology Co., Ltd patent most?

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Forevertek Biotechnology Co., Ltd's patent record in context - here's where to go next.

  • Forevertek Biotechnology Co., Ltd's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
  • Ranked #26,329 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Forevertek Biotechnology Co., Ltd against For Life Products, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.